|
Hypertrophy
Citations 191-200 of 685 total displayed.
|
Past content
(since Mar 1999):
|
- XVIIth Scientific Meeting of the Inter-American Society of Hypertension
Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension
- Gil F. Salles, Roberto Fiszman, Claudia R.L. Cardoso, and Elizabeth S. Muxfeldt
Hypertension 2007;50:723-728; published online before print as doi:10.1161/HYPERTENSIONAHA.107.093120
[Abstract]
[Full text]
- Scientific Contributions
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
- Peter M. Okin, Richard B. Devereux, Katherine E. Harris, Sverker Jern, Sverre E. Kjeldsen, Lars H. Lindholm, Björn Dahlöf LIFE Study Investigators
Hypertension published September 24, 2007, doi:10.1161/HYPERTENSIONAHA.107.096818
[Abstract]
- Editorial Commentary
Left Ventricular Hypertrophy Reversal and Prevention of Diabetes. Two Birds With One Stone?
- Giuseppe Schillaci, Matteo Pirro, and Elmo Mannarino
Hypertension published September 24, 2007, doi:10.1161/HYPERTENSIONAHA.107.099747
[Abstract]
- Scientific Contributions
Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism
- Cristiana Catena, GianLuca Colussi, Roberta Lapenna, Elisa Nadalini, Alessandra Chiuch, Pasquale Gianfagna, and Leonardo A. Sechi
Hypertension published September 24, 2007, doi:10.1161/HYPERTENSIONAHA.107.095448
[Abstract]
- Scientific Contributions
Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension
- Begoña López, José M. Castellano, Arantxa González, Joaquín Barba, and Javier Díez
Hypertension published September 10, 2007, doi:10.1161/HYPERTENSIONAHA.107.098111
[Abstract]
- Hypertension Highlights
Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2-Angiotensin-(1-7)-Mas Receptor Axis. More Than Regulation of Blood Pressure?
- Mark C. Chappell
Hypertension published September 4, 2007, doi:10.1161/HYPERTENSIONAHA.106.076216
[Abstract]
- Editorial Commentaries
Promise of Mineralocorticoid Receptor Blockade in Asymptomatic Left Ventricular Dysfunction
- Bertram Pitt
Hypertension 2007;50:461-462; published online before print as doi:10.1161/HYPERTENSIONAHA.107.095356
[Full text]
- Editorial Commentaries
Lipids and the Heart: Neither Feast nor Famine
- Denis J. Glenn and David G. Gardner
Hypertension 2007;50:463-464; published online before print as doi:10.1161/HYPERTENSIONAHA.107.095612
[Full text]
- Original Articles
Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension
- Nathan K. LeBrasseur, Toni-Ann S. Duhaney, Deepa S. De Silva, Lei Cui, Peter C. Ip, Lija Joseph, and Flora Sam
Hypertension 2007;50:489-496; published online before print as doi:10.1161/HYPERTENSIONAHA.107.092403
[Abstract]
[Full text]
- Original Articles
Pressure Overload-Induced Cardiomyopathy in Heterozygous Carrier Mice of Carnitine Transporter Gene Mutation
- Ryotaro Takahashi, Toru Asai, Hisashi Murakami, Ryuichiro Murakami, Michitaka Tsuzuki, Yasushi Numaguchi, Hideo Matsui, Toyoaki Murohara, and Kenji Okumura
Hypertension 2007;50:497-502; published online before print as doi:10.1161/HYPERTENSIONAHA.107.088609
[Abstract]
[Full text]
|
|
